Navigation Links
Isis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
Date:2/28/2012

CARLSBAD, Calif., Feb. 28, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Cowen and Company's 32nd Annual Health Care Conference on Tuesday, March 06, 2012 at 10:40 a.m. ET at the Boston Marriot Copley Place.  

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 26 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... -- RadiologyAuction will have their first auction starting May 5 ... the end of the auction on May 27 th ... Cr,s, Agfa and Sony, printers and GE portable x-rays ... equipment will be available at later auctions each month ... buying and selling imaging equipment, the brokers at RadiologyAuction ...
(Date:5/4/2015)... -- Makindus, Inc. a specialty pharmaceutical development company focused on ... has granted orphan drug designation for their lead candidate, ... "We are extremely pleased to now have orphan drug ... for Europe . This complements and ... States for which orphan designation has already ...
(Date:5/4/2015)... , May 4, 2015   HeartWare International, Inc ... invasive, miniaturized circulatory support technologies that are revolutionizing the treatment ... Doug Godshall , is scheduled to present at the ... Las Vegas on Thursday, May 14, ... The live webcast of the Company,s presentation at the conference ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
... As part of the Help America ... the first approved candidate with hearing instruments at no ... came into the Beaverton clinic because of hearing concerns. ... those that have hearing loss and limited financial resources ...
... Spectrum Control, Inc. (Nasdaq: SPEC ), a leading ... today that it will release its fourth quarter and fiscal ... close of the market. Following the release, Spectrum Control will ... discuss the Company,s operating results for the quarter and fiscal ...
Cached Medicine Technology:Accurate Hearing & Audiology Clinics / Help America Hear - One Person at a Time 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 The U.S. ... baby boomers join the ranks of senior citizens (1) ... on an already over-burdened healthcare system. Additionally, as older ... to replace them. Per the U.S. Census Bureau, the ... to increase 75% by 2050 while those 25 to ...
(Date:5/4/2015)... WA (PRWEB) May 04, 2015 EyeCRO ... a collaboration to facilitate development of NM108, a first-in-class ... that lead to blindness, including Diabetic Retinopathy. The ... platform developed by EyeCRO, which can deliver drugs to ... topical eyedrop. , Under the terms of the ...
(Date:5/4/2015)... Ill., (PRWEB) May 04, 2015 New ... American Brain Tumor Association (ABTA) show that people diagnosed ... diagnosis and treatment options, including clinical trials, at the ... days to make difficult decisions about their course of ... launch of the first nationwide brain tumor volunteer network, ...
(Date:5/4/2015)... May 04, 2015 Sheltering Arms announced ... from Hale House. The Mother Hale Learning Center meets ... Early Childhood Education. Sheltering Arms will begin operating the ... be served by the center. , Opened in 2006, ... six weeks to five years, many of whom come ...
(Date:5/4/2015)... May 04, 2015 Elisabeth Rosenthal’s ... a stir and showed the healthcare fraternity as ... healthcare procedure, the downside of balance billing. In ... healthcare provider billing a patient for the difference ... reimburse and what the provider chooses to charge. ...
Breaking Medicine News(10 mins):Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3
... Saturday staged the Gay Pride parade in Rome, urging ... couples legal status and override Vatican objections . ... and lawmakers, marched under a baking sun from Rome's ... Lateran, the official ecclesiastical seat of the Pope as ...
... non-invasive screening in early pregnancy reduces Down's syndrome ... Brndum-Nielsen, of the Kennedy Institute, Glostrup, Denmark, has ... ultrasound early in pregnancy, combined with maternal blood ... in Denmark with Down Syndrome by 50 percent. ...
... has identified a gene responsible for otosclerosis - the ... adults . ,Melissa Thys, from the Department ... this finding may be a step towards new treatments ... ,Otosclerosis is a multifactorial disease, caused by ...
... study has found that waiting just two minutes to cut ... health boost as it reduces the risk of blood disorders ... McMaster University in Hamilton, Canada, and involved more than 1,900 ... the university, said that the results showed that as little ...
... partly to blame for the conflict in Sudan's Darfur ... U.N. Secretary-General Ban Ki-moon said in an editorial published ... in convenient military and political shorthand - an ethnic ... Ban wrote in The Washington Post. "Look to its ...
... The researchers identified individual genes that are associated with ... future studies that may significantly enhance the ability to ... respond to treatment,using a functional genomic screen. ... treatment failure in patients with metastatic cancer. Dr. Julian ...
Cached Medicine News:Health News:Gay Pride Attracts Tens of Thousands in Rome 2Health News:Non-invasive Screening in Early Pregnancy Halves Down's Syndrome Births 2Health News:Boffin Identifies Gene Causing Otosclerosis 2Health News:2 Minute Delay in Cutting Cord can Give Babies a 'significant' Health Boost 2Health News:Climatic Change Cause of Dafur Conflict-UN 2Health News:New Genetic Studies Carried Out in Cancer Therapy 2
4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology....
Agglutinating sera for serological identification of E. coli by slide and/or tube agglutination tests. Agglutinating sera are packaged 2 mL / vial....
For presumptive identification of Escherichia coli using enzyme technology. Tests: Indole, MUG...
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens....
Medicine Products: